Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS

Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome

(2020) Eylem Karatay et al.   Turkish Journal of Gastroenterology

Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.

(2018) Hannah Ceuleers et al.   BRITISH JOURNAL OF PHARMACOLOGY

1092 - Food Antigen-Specific Sensitization of Nociceptive Nerves as an Underlying Mechanism of Visceral Pain in Ibs

(2018) Javier Aguilera-Lizarraga et al.   GASTROENTEROLOGY

New treatments and therapeutic targets for IBS and other functional bowel disorders

(2018) Magnus Simrén et al.   Nature Reviews Gastroenterology & Hepatology

Food Antigen-Specific Antibodies and Mast Cell Activation in Post-Infectious Visceral Hypersensitivity

(2017) Morgane Florens et al.   GASTROENTEROLOGY

Limb proportions show developmental plasticity in response to embryo movement

(2017) A. S. Pollard et al.   Scientific Reports

Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome

(2016) Mira M. Wouters et al.   GASTROENTEROLOGY

The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review

(2016) Ami D Sperber et al.   GUT

Topical delivery of aqueous micellar resolvin E1 analog (RX-10045)

(2016) Kishore Cholkar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

(2016) Young-Sun Lee et al.   MEDIATORS OF INFLAMMATION

Effect of genetic background and postinfectious stress on visceral sensitivity inCitrobacter rodentium-infected mice

(2016) S. U. Mondelaers et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Design and Synthesis of Cyclopropane Congeners of Resolvin E2, an Endogenous Proresolving Lipid Mediator, as Its Stable Equivalents

(2016) Hayato Fukuda et al.   ORGANIC LETTERS

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments

(2016) Mohammad H Farzaei et al.   Journal of Neurogastroenterology and Motility

245 Evidence for a New Mechanism Underlying Persistent Visceral Hypersensitivity and Increased Permeability in a Model of Post-Infectious IBS

(2015) Javier Aguilera-Lizarraga et al.   GASTROENTEROLOGY

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome

(2015) Nicolas Cenac et al.   GASTROENTEROLOGY

Identification of resolvin D2 receptor mediating resolution of infections and organ protection

(2015) Nan Chiang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Human milk proresolving mediators stimulate resolution of acute inflammation

(2015) H Arnardottir et al.   Mucosal Immunology

Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice

(2014) Caroline P. Klein et al.   NEUROPHARMACOLOGY

The effect of chemically induced colitis, psychological stress and their combination on visceral pain in female Wistar rats

(2014) Annemie Deiteren et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Lipid Mediators in the Resolution of Inflammation

(2014) Charles N. Serhan et al.   Cold Spring Harbor Perspectives in Biology

The epidemiology of irritable bowel syndrome

(2014) Timothy Card et al.   Clinical Epidemiology

Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2

(2013) Eduardo E Valdez-Morales et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

TRP Channels and Pain

(2013) David Julius   Annual Review of Cell and Developmental Biology

Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery

(2013) Yousuf M AlSuleimani et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Diagnostic Function of OCT in Diabetic Maculopathy

(2013) Bartosz L. Sikorski et al.   MEDIATORS OF INFLAMMATION

Resolvin D1 and its GPCRs in resolution circuits of inflammation

(2013) Antonio Recchiuti   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Effect of Gender on Prevalence of Irritable Bowel Syndrome in the Community: Systematic Review and Meta-Analysis

(2012) Rebecca M Lovell et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Revision of the Atlanta classification of acute pancreatitis: the editorial perspective

(2012) Thomas M Gress et al.   GUT

Nerve activity recordings in routine human intestinal biopsies

(2012) Carla Cirillo et al.   GUT

Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

(2012) Patrick A Hughes et al.   GUT

Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception

(2012) Ajay S. Yekkirala   LIFE SCIENCES

Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation

(2012) Karsten H. Weylandt et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats

(2011) JF Lima-Garcia et al.   BRITISH JOURNAL OF PHARMACOLOGY

Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice

(2011) A. F. Bento et al.   JOURNAL OF IMMUNOLOGY

Resolvin D2 Is a Potent Endogenous Inhibitor for Transient Receptor Potential Subtype V1/A1, Inflammatory Pain, and Spinal Cord Synaptic Plasticity in Mice: Distinct Roles of Resolvin D1, D2, and E1

(2011) C.-K. Park et al.   JOURNAL OF NEUROSCIENCE

Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX)

(2011) Supachoke Mangmool et al.   Toxins

The Immune System in Irritable Bowel Syndrome

(2011) Giovanni Barbara et al.   Journal of Neurogastroenterology and Motility

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress

(2010) María Vicario et al.   BRAIN BEHAVIOR AND IMMUNITY

Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception

(2010) S Bang et al.   BRITISH JOURNAL OF PHARMACOLOGY

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

(2010) T. K. Klooker et al.   GUT

Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions

(2010) Zhen-Zhong Xu et al.   NATURE MEDICINE

Resolvins: Natural agonists for resolution of pulmonary inflammation

(2010) Mohib Uddin et al.   PROGRESS IN LIPID RESEARCH

Molecular basis of mechanosensitivity

(2009) Stuart M. Brierley   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Mediators and receptors in the resolution of inflammation: drug targeting opportunities

(2009) AG Stewart   BRITISH JOURNAL OF PHARMACOLOGY

Activation of Human Enteric Neurons by Supernatants of Colonic Biopsy Specimens From Patients With Irritable Bowel Syndrome

(2009) Sabine Buhner et al.   GASTROENTEROLOGY

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

(2009) Matthew Spite et al.   NATURE

Contributions of Pain Sensitivity and Colonic Motility to IBS Symptom Severity and Predominant Bowel Habits

(2008) Motoyori Kanazawa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Symptom Severity but Not Psychopathology Predicts Visceral Hypersensitivity in Irritable Bowel Syndrome

(2008) Patrick P.J. van der Veek et al.   Clinical Gastroenterology and Hepatology